ACLARION INC (ACON) Fundamental Analysis & Valuation

NASDAQ:ACON • US6551874091

3.28 USD
+0.02 (+0.61%)
At close: Mar 10, 2026
3.1548 USD
-0.13 (-3.82%)
After Hours: 3/10/2026, 5:54:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ACON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, ACON scores 3 out of 10 in our fundamental rating. ACON was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for ACON as it has an excellent financial health rating, but there are worries on the profitability. ACON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. ACON Profitability Analysis

1.1 Basic Checks

  • In the past year ACON has reported negative net income.
  • ACON had a negative operating cash flow in the past year.
  • ACON had negative earnings in each of the past 5 years.
  • In the past 5 years ACON always reported negative operating cash flow.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -55.97%, ACON is doing worse than 82.86% of the companies in the same industry.
  • ACON has a worse Return On Equity (-59.10%) than 60.00% of its industry peers.
Industry RankSector Rank
ROA -55.97%
ROE -59.1%
ROIC N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ACON Health Analysis

2.1 Basic Checks

  • ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ACON has more shares outstanding than it did 1 year ago.
  • ACON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • ACON has an Altman-Z score of 1.27. This is a bad value and indicates that ACON is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.27, ACON is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • There is no outstanding debt for ACON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACCN/A
WACC9.22%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

  • A Current Ratio of 17.01 indicates that ACON has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 17.01, ACON belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Quick Ratio of 17.01 indicates that ACON has no problem at all paying its short term obligations.
  • ACON has a better Quick ratio (17.01) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 17.01
Quick Ratio 17.01
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ACON Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 93.93% over the past year.
  • Looking at the last year, ACON shows a very strong growth in Revenue. The Revenue has grown by 36.71%.
  • The Revenue has been decreasing by -8.83% on average over the past years.
EPS 1Y (TTM)93.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
Revenue 1Y (TTM)36.71%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%35.71%

3.2 Future

  • Based on estimates for the next years, ACON will show a very strong growth in Earnings Per Share. The EPS will grow by 41.36% on average per year.
  • Based on estimates for the next years, ACON will show a very strong growth in Revenue. The Revenue will grow by 58.97% on average per year.
EPS Next Y99.79%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year40%
Revenue Next 2Y58.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -100K -200K -300K

More info and screens

Find the best growth stocksShow best growing peers

1

4. ACON Valuation Analysis

4.1 Price/Earnings Ratio

  • ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800

4.3 Compensation for Growth

  • ACON's earnings are expected to grow with 41.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACON Dividend Analysis

5.1 Amount

  • ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACON Fundamentals: All Metrics, Ratios and Statistics

ACLARION INC

NASDAQ:ACON (3/10/2026, 5:54:24 PM)

After market: 3.1548 -0.13 (-3.82%)

3.28

+0.02 (+0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners0.73%
Inst Owner Change-22.2%
Ins Owners0%
Ins Owner Change0%
Market Cap9.35M
Revenue(TTM)67.40K
Net Income(TTM)-7.39M
Analysts82.86
Price Target23.46 (615.24%)
Short Float %5.97%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.47%
Min EPS beat(2)-19.3%
Max EPS beat(2)-9.64%
EPS beat(4)2
Avg EPS beat(4)25.55%
Min EPS beat(4)-19.3%
Max EPS beat(4)99.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-45.15%
Min Revenue beat(2)-53.43%
Max Revenue beat(2)-36.86%
Revenue beat(4)0
Avg Revenue beat(4)-41.65%
Min Revenue beat(4)-53.43%
Max Revenue beat(4)-36.86%
Revenue beat(8)0
Avg Revenue beat(8)-50.65%
Revenue beat(12)1
Avg Revenue beat(12)-43.69%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-30%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 138.69
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-801.7
EYN/A
EPS(NY)-13.98
Fwd EYN/A
FCF(TTM)-2.34
FCFYN/A
OCF(TTM)-2.27
OCFYN/A
SpS0.02
BVpS4.39
TBVpS3.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -55.97%
ROE -59.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.2%
Cap/Sales 331.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.01
Quick Ratio 17.01
Altman-Z 1.27
F-Score5
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)128.54%
Cap/Depr(5y)106.31%
Cap/Sales(3y)402.91%
Cap/Sales(5y)349.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
EPS Next Y99.79%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)36.71%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%35.71%
Revenue Next Year40%
Revenue Next 2Y58.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-59.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.57%
OCF growth 3YN/A
OCF growth 5YN/A

ACLARION INC / ACON FAQ

What is the ChartMill fundamental rating of ACLARION INC (ACON) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACON.


What is the valuation status of ACLARION INC (ACON) stock?

ChartMill assigns a valuation rating of 1 / 10 to ACLARION INC (ACON). This can be considered as Overvalued.


How profitable is ACLARION INC (ACON) stock?

ACLARION INC (ACON) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ACON stock?

The Earnings per Share (EPS) of ACLARION INC (ACON) is expected to grow by 99.79% in the next year.